About 630 results

ALLMedicine™ Protein-losing Enteropathy Center

Research & Reviews  240 results

Protein-losing enteropathy recurrence after pediatric heart transplantation: Multicente...
Pediatric Transplantation; Sagray E, Johnson JN et. al.

Apr 23rd, 2022 - Protein-losing enteropathy (PLE) is a devastating complication of the Fontan circulation. Although orthotopic heart transplantation (HTx) typically results in resolution of PLE symptoms, isolated cases of PLE relapse have been described after HTx....

Surgical and interventional rescue strategies for Fontan failure.
Interactive Cardiovascular and Thoracic Surgery; Gierlinger G, Sames-Dolzer E et. al.

Apr 20th, 2022 - Fontan patients are at lifelong risk for developing complications which may result in Fontan failure. Survival rates after heart transplantation (HTX) are still unsatisfying in these patients. Long term survival of extracardiac Fontan patients in ...

CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a-) v...
Human Genetics; Kurolap A, Hagin D et. al.

Mar 23rd, 2022 - The complement system regulator CD55 was initially found to carry the Cromer blood group system antigens, and its complete loss of function was subsequently revealed to cause a severe monogenic gastrointestinal syndrome characterized by protein-lo...

Plastic Bronchitis and Protein-Losing Enteropathy in the Fontan Patient: Evolving Under...
The Canadian Journal of Cardiology; Mackie AS, Veldtman GR et. al.

Mar 23rd, 2022 - Plastic bronchitis (PB) and protein-losing enteropathy (PLE) are rare but potentially devastating complications of the Fontan circulation. PB occurs in ∼4% of Fontan patients, typically presents within 2-3 years of Fontan completion with chronic c...

Nutritional status in eosinophilic gastrointestinal disorders: A pediatric case-control...
Pediatric Allergy and Immunology : Official Publication O... Votto M, Bonitatibus G et. al.

Jan 27th, 2022 - Eosinophilic gastrointestinal disorders (EGIDs) represent an emerging group of heterogeneous diseases associated with failure to thrive, weight loss, protein-losing enteropathy, and malnutrition. To date, no studies have assessed the nutritional s...

see more →

Clinicaltrials.gov  4 results

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

Jan 11th, 2022 - For infants and newborns who have a heart defect at birth that leaves them with one functional ventricle, there is a series of surgeries that are required to allow survival. These surgeries ultimately lead to a common heart and great blood vessel ...

Lymphatic Morphology of Fontan Patients

Apr 28th, 2021 - The Fontan procedure has revolutionized the treatment of patients born with a congenital univentricular heart defect. However, over time, it is associated with severe lymphatic complications such as plastic bronchitis, protein-losing enteropathy (...

Lymphatic Function in Patients With a Fontan-Kreutzer Circulation

Dec 20th, 2017 - Background: The lymphatics regulate the interstitial fluid by removing excessive fluid. It represents an extremely important step in the prevention of edema. The Fontan-Kreutzer procedure has revolutionized the treatment of univentricular hearts. ...

Intra-Atrial vs. Extra-Cardiac Technique During Fontan Operation

May 23rd, 2007 - The Fontan procedure is indicated as final-stage treatment for pediatric cardiac patients with single ventricle physiology. This procedure, whose aim is to provide for total cavopulmonary disconnect and perfusion of the pulmonary arteries via syst...

see more →

News  8 results

Pembrolizumab Plus Gemcitabine/Hypofractionated Radiotherapy Demonstrates Promising Efficacy in Muscle-Invasive Bladder Cancer

Mar 1st, 2022 - Pembrolizumab (Keytruda) in combination with gemcitabine and concurrent hypofractionated radiotherapy (RT) appears to be a promising and efficacious, bladder-sparing regimen for patients with muscle-invasive bladder cancer (MIBC), according to fin...

What is your diagnosis? - September 2019
Obaidullah Aseem, MD, Daniel S. Childs, MD et. al.

Aug 26th, 2019 - Erosive protein-losing enteropathy secondary to disseminated histoplasmosis This patient was treated with amphotericin B and transitioned to oral itraconazole with frequent blood level monitoring to ensure absorption. His symptoms improved gradual.

What is your diagnosis? - September 2019
Obaidullah Aseem, MD, Daniel S. Childs, MD et. al.

Aug 26th, 2019 - Erosive protein-losing enteropathy secondary to disseminated histoplasmosis This patient was treated with amphotericin B and transitioned to oral itraconazole with frequent blood level monitoring to ensure absorption. His symptoms improved gradual.

Post-Fontan Health Screening 'Toolkit' Proposed by AHA

Jul 2nd, 2019 - With improving survival after the Fontan procedure, adult survivors need periodic cardiovascular and end-organ surveillance testing, according to a scientific statement from the American Heart Association (AHA). Globally, the population of adults ...

January 2019 - What's your diagnosis?
Jen-Wei Chou, MD, Ken-Sheng Cheng, MD et. al.

Jan 2nd, 2019 - Primary intestinal lymphangiectasia Histologic examination shows chronic inflammation of the ileum characterized by increased lymphoplasma cell infiltration of lamina propria without malignancy. Moreover, marked dilatation of lymphatic ducts that.

see more →